ENHT yields 2000000.00% · PFE yields 6.13%● Live data
📍 ENHT pulled ahead of the other in Year 1
Combined, ENHT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENHT + PFE for your $10,000?
enherent Corp. operates as an information technology (IT) services company in the northeastern United States. The company offers IT consultative resource and staffing services to augment client resource demands in the areas of project management, business analysis, systems architecture and design, database architecture and design, application code development, network engineering, and quality assurance and testing. Its application development services comprise planning, design, application code development, testing, and deployment of enhancements to existing systems or new custom application development; and evaluation and implementation of third party business application software. The company's network and security services include planning, architecture, design, and engineering to support the build out, optimization, and security audits of the network infrastructure, as well as implementation of software product licenses or computer equipment. It also provides systems integration services, such as conducting application, data, and technical assessments to determining gaps in the existing environment; making recommendations to address the gaps by leveraging existing IT assets; deploying a combination of application code development, software product implementation, and computer equipment; and integrating new capabilities into the environment to address the gaps. In addition, the company offers advanced analytics that leverages text analytics technology to understand and process free-form text. It serves insurance, financial services, banking and capital markets, retail distribution, apparel, health care, pharmaceutical, and consumer goods industries. The company is headquartered in Syosset, New York.
Full ENHT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.